leuprolide and Vascular-Diseases

leuprolide has been researched along with Vascular-Diseases* in 2 studies

Trials

2 trial(s) available for leuprolide and Vascular-Diseases

Article	Year
Hemorheologic profile in healthy women undergoing controlled ovarian stimulation. Fertility and sterility, 2011, Volume: 95, Issue:1 We investigated the hemorheologic profile in 110 women undergoing controlled ovarian stimulation and provide evidence that smokers and women with body mass index>25 kg/m2 exhibit alterations of rheologic profile. A progressive increase of whole-blood viscosity throughout the ovarian stimulation cycle was observed; deformability and aggregation of erythrocytes decreased from baseline to the beginning of recombinant FSH administration, then remained unchanged throughout the next days; hematocrit mildly decreased during the last days of recombinant FSH administration; and fibrinogen and cholesterol levels decreased and increased, respectively, throughout the stimulation cycle. Topics: Adult; Blood Flow Velocity; Chorionic Gonadotropin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Hemorheology; Hormones; Humans; Infertility, Female; Leuprolide; Ovulation Induction; Risk Factors; Sperm Injections, Intracytoplasmic; Vascular Diseases; Young Adult	2011
Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease. Blood, 1999, May-01, Volume: 93, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hormone Replacement Therapy; Humans; Leukemia; Leuprolide; Lymphoma; Middle Aged; Premenopause; Risk Factors; Uterine Hemorrhage; Vascular Diseases	1999

Article

Year

Hemorheologic profile in healthy women undergoing controlled ovarian stimulation.

Fertility and sterility, 2011, Volume: 95, Issue:1

We investigated the hemorheologic profile in 110 women undergoing controlled ovarian stimulation and provide evidence that smokers and women with body mass index>25 kg/m2 exhibit alterations of rheologic profile. A progressive increase of whole-blood viscosity throughout the ovarian stimulation cycle was observed; deformability and aggregation of erythrocytes decreased from baseline to the beginning of recombinant FSH administration, then remained unchanged throughout the next days; hematocrit mildly decreased during the last days of recombinant FSH administration; and fibrinogen and cholesterol levels decreased and increased, respectively, throughout the stimulation cycle.

Topics: Adult; Blood Flow Velocity; Chorionic Gonadotropin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Hemorheology; Hormones; Humans; Infertility, Female; Leuprolide; Ovulation Induction; Risk Factors; Sperm Injections, Intracytoplasmic; Vascular Diseases; Young Adult

2011

Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.

Blood, 1999, May-01, Volume: 93, Issue:9

Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hormone Replacement Therapy; Humans; Leukemia; Leuprolide; Lymphoma; Middle Aged; Premenopause; Risk Factors; Uterine Hemorrhage; Vascular Diseases

1999